Empower Pharmacy supports adding seven bulk drug substances to the 503A list
It submitted comments to the FDA's Pharmacy Compounding Advisory Committee advocating for inclusion of peptides like BPC-157 and Semax.
Stay informed with the latest news and media coverage for the biggest companies in Pharmaceuticals. We track all announcements, press releases, and industry mentions in real time, all in one place. Looking for another sector? Browse our industry database.
Last updated
It submitted comments to the FDA's Pharmacy Compounding Advisory Committee advocating for inclusion of peptides like BPC-157 and Semax.
The round will advance AI-driven molecular design for drug discovery.
The data showed robust tau reduction and meaningful clinical outcomes across doses, with the 60 mg dose achieving up to 50% slowing on MMSE.
New analyses reinforce treatment effect in pure DLB and support Phase 3 dose selection.
Unlock all announcements with a free trial
Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to improve the lives of patients worldwide, today announced extended data from patients...
Outlook Therapeutics, Inc. (NASDAQ:OTLK) is one of the 10 High Growth Stocks Insiders Are Buying. On June 16, 2026, Outlook Therapeutics, Inc. (NASDAQ:OTLK) announced that...
The EGFR inhibitor for exon 20-mutated non-small cell lung cancer was developed by Shanghai-based Dizal and approved by the FDA last year.
Term Benefits of Continuous Treatment with LEQEMBI and Provide Important Insights into Treatment Experience Outside of a Clinical Trial SettingTOKYO and CAMBRIDGE, Mass., July 14...
Unlock all articles with a free trial
Track Every Market Move
Follow your target companies and get daily news updates delivered straight to your inbox
Start for freeBrowse the top companies in Pharmaceuticals and stay on top of their latest developments.